• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 13 Dec

    Quoin Pharmaceuticals Announces Dosing of First Patient in Clinical Trial in Netherton Syndrome

    Company’s Second Netherton Syndrome Clinical Study has been Cleared by FDA to Initiate Testing All Six Target Clinical Sites are on Track to be Fully Opened by Year End ASHBURN, Va., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company… Read More..

    Share this:
  • 8 Dec

    Asensus Announces Additional Senhance Surgical System Sale

    Oncology focused hospital to initiate Senhance System program RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that… Read More..

    Share this:
  • 5 Dec

    The Sustainable Green Team Joins the OTCQX Best Market

    Company's Common Stock will Continue to Trade under Existing Ticker Symbol “SGTM” NEW YORK, NY, Dec. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – The Sustainable Green Team LTD (OTCQX: SGTM), an industry-leading wholesale manufacturer and supplier of consumer and industrial wood-based mulch, soil, and lumber products nationwide, today announced… Read More..

    Share this:
« Previous 1 … 184 185 186 187 188 … 244 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact